Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 324732, 6 pages
http://dx.doi.org/10.1155/2013/324732
Research Article

Establishment of an Experimental Breast Cancer ZHENG Model and Curative Effect Evaluation of Zuo-Jin Wan

Research Center for Traditional Chinese Medicine Complexity System, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Pudong, Shanghai 201203, China

Received 18 August 2013; Accepted 22 October 2013

Academic Editor: Aiping Lu

Copyright © 2013 Jia Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. R. Shin, F. Bray et al., GLOBOCAN, 2008 V1. 2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet], International Agency for Research on Cancer, Lyon, France, 2010, http://globocan.iarc.fr/.
  2. L. Yang, L. Li, Y. Chen, and D. M. Parkin, “Cancer incidence and mortality estimates and prediction for year 2000 and 2005 in China,” Chinese Journal of Health Statistics, vol. 22, no. 4, pp. 218–222, 2005. View at Google Scholar
  3. Y. He, X. Zheng, C. Sit et al., “Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis,” Journal of Translational Medicine, vol. 10, supplement 1, p. S12, 2012. View at Publisher · View at Google Scholar
  4. Z. Chen, L. Y. Chen, P. Wang et al., “Tumor microenvironment varies under different TCM ZHENG models and correlates with treatment response to herbal medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 635702, 10 pages, 2012. View at Publisher · View at Google Scholar
  5. Q. F. Tang, X. Liu, Y. Ge et al., “Experimental study on inhibiting proliferation and inducing apoptosis of zuo jin wan alcohol extracts on human gastric cancer cells infected by Helicobacter pylori,” Chongqing Medicine, vol. 41, no. 15, pp. 1462–1464, 2012. View at Google Scholar
  6. D. C. Chao, L. J. Lin, S. T. Kao et al., “Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor-κB, and cellular transformation in HepG2 cells,” Fitoterapia, vol. 82, no. 4, pp. 696–703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Sui, X. Liu, B. H. Jin et al., “Zuo Jin Wan, a traditional Chinese herbal formula, reverses P-gp-mediated MDR in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 957078, 13 pages, 2013. View at Publisher · View at Google Scholar
  8. Xu, Y. Qi, L. Lv et al., “In vitro anti-proliferative effects of Zuojinwan on eight kinds of human cancer cell lines,” Cytotechnology, 2013. View at Google Scholar
  9. Z. Q. Fang, Z. Q. Pan, and W. L. Xu, “Methodology and purposes of establishing mouse and rat models for syndrome differentiation and treatment,” Zhong Xi Yi Jie He Xue Bao, vol. 7, no. 10, pp. 907–912, 2009. View at Google Scholar
  10. X. Zheng, Guideline for Clinical New Drug Research in Chinese Herbal Medicine, vol. 5, Chinese Medical Science and Technology Press, Beijing, China, 2002.
  11. Y. N. Song, J. J. Sun, Y. Y. Lu et al., “Therapeutic efficacy of Fuzheng-Huayu tablet based traditional Chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 709305, 8 pages, 2013. View at Publisher · View at Google Scholar
  12. S. B. Su, “Recent advance in ZHENG differentiation research in traditional Chinese medicine,” International Journal of Integrative Medicine, vol. 1, no. 7, p. 2013, 2013. View at Google Scholar
  13. C. Chai, J. Kou, D. Zhu et al., “Mice exposed to chronic intermittent hypoxia simulate clinical features of deficiency of both Qi and Yin syndrome in traditional Chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 356252, 7 pages, 2011. View at Publisher · View at Google Scholar
  14. H. Y. Dai, P. Wang, L. Feng et al., “The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth,” Integrative Cancer Therapies, vol. 9, no. 3, pp. 291–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. P. Miller, R. K. Tadagavadi, G. Ramesh, and W. B. Reeves, “Mechanisms of cisplatin nephrotoxicity,” Toxins, vol. 2, no. 11, pp. 2490–2518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Boulikas, “Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin,” Expert Opinion on Investigational Drugs, vol. 18, no. 8, pp. 1197–1218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. R. McWhinney, R. M. Goldberg, and H. L. McLeod, “Platinum neurotoxicity pharmacogenetics,” Molecular Cancer Therapeutics, vol. 8, no. 1, pp. 10–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Cohen, M. Tagliaferri, and D. Tripathy, “Traditional Chinese medicine in the treatment of breast cancer,” Seminars in Oncology, vol. 29, no. 6, pp. 563–574, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. K. Mukherjee, S. Basu, N. Sarkar, and A. C. Ghosh, “Advances in cancer therapy with plant based natural products,” Current Medicinal Chemistry, vol. 8, no. 12, pp. 1467–1486, 2001. View at Google Scholar · View at Scopus
  20. W. L. Hsiao and L. Liu, “The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights,” Planta Medica, vol. 76, no. 11, pp. 1118–1131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. X. F. Wang, J. Du, T. L. Zhang et al., “Inhibitory effects of PC-SPESII herbal extract on human breast cancer metastasis,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 894386, 11 pages, 2013. View at Publisher · View at Google Scholar
  22. F.-R. Zhao, H.-P. Mao, H. Zhang et al., “Antagonistic effects of two herbs in Zuojin Wan, a traditional Chinese medicine formula, on catecholamine secretion in bovine adrenal medullary cells,” Phytomedicine, vol. 17, no. 8-9, pp. 659–668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Wang, L. Xu, J. Peng, K. Liu, L. Zhang, and Y. Zhang, “In vivo inhibition of s180 tumors by the synergistic effect of the chinese medicinal herbs coptis chinensis and evodia rutaecarpa,” Planta Medica, vol. 75, no. 11, pp. 1215–1220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. X. N. Wang, X. Han, L.-N. Xu et al., “Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine,” Phytomedicine, vol. 15, no. 12, pp. 1062–1068, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Yang, L. Wu, S. Tashino, S. Onodera, and T. Ikejima, “Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis,” Free Radical Research, vol. 41, no. 10, pp. 1099–1108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. G. Yang, A. Q. Chen, and B. Liu, “Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205),” Chemistry and Biodiversity, vol. 6, no. 6, pp. 924–933, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Wang, Y. Cui, T. Dong, X. Zhang, and K. Lin, “Ethanol extract from a Chinese herbal formula, “zuojin Pill”, inhibit the expression of inflammatory mediators in lipopolysaccharide- stimulated RAW 264.7 mouse macrophages,” Journal of Ethnopharmacology, vol. 141, no. 1, pp. 377–385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. S. Wang, S. L. Ding, and H. P. Mao, “Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice,” Journal of Ethnopharmacology, vol. 148, no. 2, pp. 603–609, 2013. View at Google Scholar